Actively Recruiting
Longitudinal Preschool Wheeze Biomarker Study
Led by Imperial College London · Updated on 2024-04-29
150
Participants Needed
1
Research Sites
134 weeks
Total Duration
On this page
Sponsors
I
Imperial College London
Lead Sponsor
A
Action Medical Research
Collaborating Sponsor
AI-Summary
What this Trial Is About
Preschool children (aged 1-5 years) account for 75% of all UK childhood wheezing hospitalisations. This has not changed over 20 years, meaning current treatments are not working and a new approach is needed. Currently, all preschool wheezers are treated with inhaled steroids. However, only about 25% of patients, with allergies, respond well to inhaled steroids; for the other 75%, they are ineffective. This research group has found that some preschool wheezers may have other causes but there are no specific, non-invasive tests to match the right treatment to each child. The goal of this observational study is to test various bedside tests for this purpose in preschool children with wheeze, to see if they are feasible, accurate and acceptable in this age group. The research team would like to investigate the following aims: Aim 1 - To test the proposed panel of simple bedside tests below, to see how accurately they corelate with lower airway infection or inflammation. Aim 2 - To test the acceptability of these bedside tests are to parents and children, and if they reflect the child's symptoms, symptoms control and medication use. Aim 3- A small proof-of -concept study, to test if these simple bedside tests, can be used to determine treatment for each individual child. The panel of simple non-invasive tests that the research team are proposing are: 1. Skin prick tests to common allergies (house dust mite, cat, dog, grass, tree pollen, mixed moulds) 2. Finger prick blood test 3. Phlegm test for bacteria 4. Nose and throat swab for bacteria 5. Lung function test called forced oscillation technique (FOT)
CONDITIONS
Official Title
Longitudinal Preschool Wheeze Biomarker Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children aged 1 to 5 years
- More than 2 hospitalizations for acute wheeze in the last year, or
- At least 1 admission requiring high dependency unit or intravenous bronchodilator therapy in the last year
- Children undergoing bronchoscopy as part of their standard medical care (Aim 1 only)
You will not qualify if you...
- Alternative respiratory diagnosis such as cystic fibrosis or bronchiectasis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Royal Brompton Hospital
London, United Kingdom, SW3 6NP
Actively Recruiting
Research Team
C
Cheuk Fung Wong
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here